JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M608103200 on September 26, 2006

J. Biol. Chem., Vol. 281, Issue 48, 36944-36951, December 1, 2006
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
281/48/36944    most recent
M608103200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Suzuki, H.
Right arrow Articles by Horinouchi, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Suzuki, H.
Right arrow Articles by Horinouchi, S.
Related Collections
Right arrow Papers Of The Week
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Novel Benzene Ring Biosynthesis from C3 and C4 Primary Metabolites by Two Enzymes*Formula {diamondsuit}

Hirokazu Suzuki{ddagger}, Yasuo Ohnishi{ddagger}, Yasuhide Furusho{ddagger}, Shohei Sakuda§, and Sueharu Horinouchi{ddagger}1

From the {ddagger}Department of Biotechnology and §Applied Biological Chemistry, Graduate School of Agriculture and Life Sciences, University of Tokyo, Bunkyo-ku, Tokyo 113-8657, Japan

Received for publication, August 23, 2006 , and in revised form, September 26, 2006.


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS AND DISCUSSION
 REFERENCES
 
The shikimate pathway, including seven enzymatic steps for production of chorismate via shikimate from phosphoenolpyruvate and erythrose-4-phosphate, is common in various organisms for the biosynthesis of not only aromatic amino acids but also most biogenic benzene derivatives. 3-Amino-4-hydroxybenzoic acid (3,4-AHBA) is a benzene derivative serving as a precursor for several secondary metabolites produced by Streptomyces, including grixazone produced by Streptomyces griseus. Our study on the biosynthesis pathway of grixazone led to identification of the biosynthesis pathway of 3,4-AHBA from two primary metabolites. Two genes, griI and griH, within the grixazone biosynthesis gene cluster were found to be responsible for the biosynthesis of 3,4-AHBA; the two genes conferred the in vivo production of 3,4-AHBA even on Escherichia coli. In vitro analysis showed that GriI catalyzed aldol condensation between two primary metabolites, L-aspartate-4-semialdehyde and dihydroxyacetone phosphate, to form a 7-carbon product, 2-amino-4,5-dihydroxy-6-one-heptanoic acid-7-phosphate, which was subsequently converted to 3,4-AHBA by GriH. The latter reaction required Mn2+ ion but not any cofactors involved in reduction or oxidation. This pathway is independent of the shikimate pathway, representing a novel, simple enzyme system responsible for the synthesis of a benzene ring from the C3 and C4 primary metabolites.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS AND DISCUSSION
 REFERENCES
 
The shikimate pathway (Fig. 1B), involving seven enzymatic steps that produce chorismate via shikimate from phosphoenolpyruvate (PEP)2 and erythrose-4-phosphate, is well established as the common pathway for the biosynthesis of aromatic amino acids in bacteria, fungi, algae, and higher plants. Not only aromatic amino acids but also most biogenic benzene derivatives, such as p-aminobenzoic acid, m-aminobenzoic acid, 2-amino-3-hydroxybenzoic acid, 2-amino-6-hydroxybenzoic acid, and many vitamins, are derived from chorismate (1, 2). The shikimate biosynthesis pathway is also employed by Archaea, although the genes encoding the first two enzymes involved in 3-dehydroquinate (DHQ) synthesis are missing in the genomic sequences of many Archaea (3). In one of Archaea, Methanocaldococcus jannaschii, DHQ is synthesized from aspartate 4-semialdehyde (ASA) and 6-deoxy-5-ketofructose-1-phosphate by two alternative enzymes and supplied to the shikimate pathway (4). Recent studies (5, 6) showed that 3-amino-5-hydroxybenzoic acid, a precursor for ansamycin antibiotics, is also synthesized through the aminoshikimate pathway, a variant of the shikimate pathway. Thus, the benzene ring as one of the primary chemical structures in nature is extensively formed through the shikimate pathway, although some benzene derivatives are formed from aliphatic acyl-CoA by polyketide synthases (7, 8).

We recently isolated grixazone (Fig. 1A), a mixture of yellow pigments grixazone A and grixazone B, containing a phenoxazinone chromophore, as secondary metabolites of Streptomyces griseus (9, 10). In the present study on the grixazone biosynthesis, we found that 3-amino-4-hydroxybenzoic acid (3,4-AHBA, Fig. 1A) is an intermediate of grixazone. 3,4-AHBA is a benzene derivative serving as a precursor for several secondary metabolites produced by Streptomyces, such as 4-hydroxy-3-nitrosobenzamide of Streptomyces murayamaensis, asukamycin of Streptomyces nodosus, and manumycin of Streptomyces parvulus (11, 12). Although it has been proposed that 3,4-AHBA is derived from a pathway other than a shikimate-type pathway on the basis of incorporation experiments with 13C-labeled compounds in 4-hydroxy-3-nitrosobenzamide-producing S. murayamaensis (11), neither the whole picture of the 3,4-AHBA biosynthesis pathway nor the genes involved in 3,4-AHBA biosynthesis have been elucidated. Our study on the grixazone biosynthesis gene cluster has led to establishment of the biosynthesis pathway of 3,4-AHBA. Here we report a novel, simple pathway for 3,4-AHBA biosynthesis; only two enzymes are needed for the synthesis of 3,4-AHBA from C3 and C4 primary metabolites. The discovery of this pathway extends our knowledge on the biosynthesis of aromatic compounds in nature.


Figure 1
View larger version (26K):
[in this window]
[in a new window]

 
FIGURE 1.
Biosynthesis pathways of a benzene ring. A, a proposed pathway for biosynthesis of 3,4-AHBA and its derivatives in S. griseus. 3,4-AHBA is formed from ASA and DHAP through two reactions catalyzed by GriI and GriH. ASA is derived from the biosynthetic pathway for amino acids of the aspartate group and DHAP is from the glycolytic pathway. The brackets for compound 1 denote that this compound is the probable product but has not been independently characterized. B, the shikimate pathway leading to chorismate (upper) (2) and an alternative DHQ synthesis pathway, involving MJ0400 and MJ1249, established for M. jannaschii (lower) (4). DKFP, 6-deoxy-5-ketofructose-1-phosphate; E4P, erythrose-4-phosphate.

 

    EXPERIMENTAL PROCEDURES
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS AND DISCUSSION
 REFERENCES
 
Bacterial Strains, Media, and MaterialsS. griseus IFO13350 was obtained from the Institute of Fermentation, Osaka, Japan. A grixazone-nonproducing mutant strain, S. griseus M31, was derived from S. griseus IFO13350 by ultravioletmutagenesis. S. lividans TK21 was obtained from D. A. Hopwood (13). S. griseus strains were grown at 30 °C in YPD medium (0.2% yeast extract, 0.4% Bacto peptone, 0.5% NaCl, 0.2% MgSO4·7H2O, 1% glucose, and 0.5% glycine, pH 7.2) or at 26.5 °C in standard minimal medium (SMM), of which KH2PO4 was usually adjusted to 2.5 mM (10). S. lividans strains were grown at 30 °C in YEME medium (0.3% yeast extract, 0.5% Bacto peptone, 0.3% Bacto malt extract, 1% glucose, 34% sucrose, 0.5% glycine, 5 mM MgCl2, pH 7.2) (13). A thiostrepton resistance plasmid pIJ702 (14) (40-300 copies per chromosome (13)) containing the melC promoter was used for DNA manipulation and gene expression in S. griseus. For production of GriI and GriH proteins in S. lividans TK21, pIJ4123 (15) containing the thiostrepton-inducible tipA promoter, was used. Escherichia coli strains JM109, JM110, and TOP10 (Invitrogen) and plasmids pUC19 and pCR4Blunt-TOPO (Invitrogen) were used for DNA manipulation. E. coli BL21(DE3) and pET-17b were used for in vivo production of 3,4-AHBA. DNA was manipulated in Streptomyces (13) and E. coli (16) as described earlier. 3,4-AHBA was purchased from Wako Chemicals. Stable isotope-labeled compounds were purchased from Nippon Sanso. ASA was synthesized according to the method described by Black and Wright (17, 18).

Construction of Plasmids—Full details of the experimental methods are given in supplemental Methods; a summary is given below. A plasmid, pAYP20, conferring the production of a grixazone-like yellow pigment on strain M31, was isolated by shotgun cloning of a library of the chromosome of the wild-type strain. A 3.5-kb SphI fragment containing griI and griH was excised from pAYP20 and reintroduced into pIJ702 at the SphI site in the same direction as that on pAYP20, resulting in pAYP25. The griI-griH, griI, and griH sequences were amplified by PCR and cloned in a pIJ702-derived plasmid, in which the melC1-melC2 sequence under the melC promoter was replaced by a short linker, resulting in pAYP26, pAYP27, and pAYP28, respectively. On these plasmids, griI and griH were under the control of the melC promoter. For protein preparation, the griI and griH sequences were also cloned in pIJ4123, resulting in pIJ4123-griI and pIJ4123-griH, in which griI and griH were both under the control of the thiostrepton-inducible tipA promoter. The co-translational griI-griH sequence was generated by PCR and cloned into pET-17b for expression in E. coli, resulting in pET-griIH, in which the co-translational griI-griH sequence was under the control of the T7 promoter.

3,4-AHBA Production in VivoS. griseus M31 [pAYP20, pAYP25, or pAYP26]3 was precultured at 30 °C for 2 days in 100 ml of YPD medium supplemented with 10 µg/ml thiostrepton. The mycelium was harvested by centrifugation, washed two times, resuspended in 10 ml of SMM, and homogenized. A portion (100 µl) of the homogenized solution was inoculated to 100 ml of fresh SMM and cultured at 26.5 °C for 5 days. For 3,4-AHBA production in E. coli BL21(DE3) harboring pET-griIH, the cells were cultured at 26.5 °C for 24 h in M9 medium supplemented with 50 µg/ml ampicillin, 1% (v/v) glycerol, 1% (w/v) asparagine, and 1% (w/v) lactose. The culture broth was passed through a 0.2-µm membrane, and 3,4-AHBA in the broth was analyzed by reversed-phase high performance liquid chromatography (HPLC) and liquid chromatography-electrospray ionization mass spectrometry (LC-ESIMS).

HPLC and LC-ESIMS Analysis—HPLC analysis was carried out by using the Waters 600 HPLC system equipped with the Waters 996 photodiode array detector. Conditions for HPLC were as follows: column, Senshu Pak Docosil-B (4.6 x 250 mm, Senshu Kagaku); column temperature, 30 °C; flow rate, 1 ml/min. After 10 µl of the reaction mixture had been injected into the column equilibrated with 0.1% trifluoroacetic acid in water, the column was initially developed isocratically for 3 min, followed by development by a linear gradient from 0 to 90% acetonitrile in water containing 0.1% trifluoroacetic acid for 15 min. LC-ESIMS analysis was carried out by using a HPLC system (model 1100 series, Agilent Technologies) equipped with a mass spectrometer (Bruker HCT plus, Bruker Daltonics) with the ESI-positive/negative mode. HPLC was conducted using a Senshu Pak Docosil-B (2.6 x 250 mm, Senshu Kagaku) at a flow rate of 0.2 ml/min. After injection of the sample into the column equilibrated with 0.1% acetic acid in water, the column was initially developed isocratically for 10 min, followed by development by a linear gradient from 0 to 100% acetonitrile in water containing 0.1% acetic acid for 10 min.

Structure Analyses—Full details of purification of compounds are given in supplemental Methods. S. griseus M31 [pAYP20, pAYP25, or pAYP26] produced compounds, 2, 4, and 5 (see Fig. 2C, panel a). S. griseus M31 [pAYP20] was cultured at 26.5 °C in SMM with rotary shaking. The culture supernatant was adjusted to pH 2.5 and treated with ethyl acetate. By preparative HPLC, compound 2 was purified from the aqueous fraction and compound 4 was purified from the ethyl acetate fraction. Compound 5, which was formed from commercially available 3,4-AHBA by aerobic incubation of it at 26.5 °C for 5 days in aseptic SMM, was purified by ethyl acetate extraction and preparative HPLC. Compound 5 was confirmed to be identical to the yellow pigment produced by S. griseus M31 [pAYP20] by HPLC and LC-ESIMS. Compound 3, produced by S. lividans [pIJ4123-griI], was purified from the culture supernatant by ethyl acetate extraction, ion exchange chromatography, chromatography on silica, and preparative HPLC. 3,4-AHBA (2), 3-acetylamino-4-hydroxybenzoic acid (4, 3,4-AcAHBA), 2-aminophenoxazin-3-one-8-carboxylic acid (5, APOC), and 5-acetyl-1H-pyrrole-2-carboxylic acid (3, 5,2-APC) were identified on the basis of the following spectroscopic parameters (see Fig. 1A).

3,4-AHBA (2): 1H NMR (500 MHz, D2O): {delta} 7.83 (d, J = 2.5 Hz, 1H, benzene 2-H), 7.83 (dd, J = 9.0, 2.0 Hz, 1H, benzene 6-H), 6.98 (d, J = 9.0 Hz, 1H, benzene 5-H); 13C NMR (125 MHz, D2O): {delta} 170.2 (COOH), 155.4 (benzene 4-C), 132.8 (benzene 6-C), 126.4 (benzene 3-C), 122.8 (benzene 2-C), 119.1 (benzene 1-C), 117.0 (benzene 5-C); high resolution electrospray ionization-time-of-flight mass spectrum (HRESI/TOFMS), m/z 154.0522 [M + H]+ (calculated for C7H8NO3, 1.8 millimass units error).

5,2-APC (3): 1H NMR (500 MHz, Me2SO-d6): {delta} 6.94 (d, J = 4.0, 2.0 Hz, 1H, pyrrole 3-H), 6.76 (dd, J = 4.0, 2.0 Hz, 1H, pyrrole 4-H), 2.42 (s, 3H, COCH3); 13C NMR (125 MHz, Me2SO-d6) {delta} 188.4 (COCH3), 161.5 (COOH), 134.9 (pyrrole 5-C), 128.2 (pyrrole 2-C), 116.1 (pyrrole 3-C), 115.1 (pyrrole 4-C), 26.5 (COCH3); ESIMS, m/z 152.2 [M - H]-. They were in good agreement with those of 5,2-APC (19).

3,4-AcAHBA (4): 1H NMR (500 MHz, Me2SO-d6): {delta} 10.69 (s, 1H, OH), 9.30 (s, 1H, NH), 8.43 (d, J = 2.0 Hz, 1H, benzene 2-H), 7.56 (dd, J = 8.0, 2.0 Hz, 1H, benzene 6-H), 6.92 (d, J = 8.5 Hz, 1H, benzene 5-H), 2.10 (s, 3H, COCH3); 13C NMR (125 MHz, Me2SO-d6): {delta} 169.1 (COCH3), 167.3 (COOH), 152.0 (benzene 4-C), 126.5 (benzene 6-C), 126.2 (benzene 3-C), 123.8 (benzene 2-C), 121.4 (benzene 1-C), 115.1 (benzene 5-C), 23.8 (COCH3); HRESI/TOF-MS, m/z 196.0596 [M + H]+ (calculated for C9H9NO4, 1.4 millimass units error).

APOC (5): 1H NMR (500 MHz, Me2SO-d6): {delta} 8.16 (d, J = 2.0 Hz, 1H, 9-H), 7.96 (dd, J = 8.5, 2.5 Hz, 1H, 7-H), 7.57 (d, J = 9.0 Hz, 1H, 6-H), 6.41 (s, 1H, 1-H), 6.36 (s, 1H, 4-H); 13C NMR (125 MHz, Me2SO-d6): {delta} 180.5 (3-C), 166.4 (11-C), 149.0, 148.7, 147.7 (10a-C, 4a-C, and 2-C), 144.9 (5a-C), 133.4, 127.6 (9a-C and 8-C), 129.1 (7-C), 129.0 (9-C), 116.4 (6-C), 104.1 (1-C), 98.3 (4-C); HRESI/TOF-MS, m/z 257.05540 [M + H]+ (calculated for C13H9N2O4, 0.83 millimass unit error).

Incorporation of 13C-Labeled Precursors into 3,4-AcAHBA S. griseus M31 [pAYP25] was cultured at 26.5 °C for about 2 days in 50 ml of SMM with reciprocal shaking until 3,4-AHBA had just started to be produced in the culture broth. The mycelium was harvested and washed three times with carbon source (0.9% glucose and 0.9% asparagine)-depleted SMM. The mycelium was suspended in 50 ml of the same fresh SMM containing a stable isotope-labeled compound (Table 1). After further cultivation at 26.5 °C for 3 days, 3,4-AcAHBA accumulated in the culture broth was purified by preparative HPLC (see supplemental Methods). Incorporation of labeled precursors into 3,4-AcAHBA was determined by 13C NMR.


View this table:
[in this window]
[in a new window]

 
TABLE 1
Incorporation of 13C-labeled compounds into 3,4-AcAHBA

 
Preparation of GriI and GriH ProteinsS. lividans TK21 [pIJ4123-griI] and S. lividans TK21 [pIJ4123-griH] were cultured at 30 °C for 2 days in YEME medium supplemented with 5 µg/ml kanamycin. The tipA promoter was induced by 5 µg/ml thiostrepton and the cultivation was further continued for 2 days. All operations described below were carried out at 4 °C. Cells (5 ml wet volume) were harvested by centrifugation and resuspended in 5 ml of buffer A (50 mM sodium phosphate, pH 8.0, 0.5 M NaCl, and 20% glycerol) containing 2 mg/ml lysozyme. After incubation of the mixture on ice for 30 min, the cell suspension was sonicated for 3 min and then centrifuged at 10,000 x g for 10 min to remove cell debris. Polyethyleneimine was added to the supernatant to give a final concentration of 0.1% (w/v), followed by centrifugation of the mixture at 20,000 x g for 20 min. The supernatant, to which imidazole was added to give a final concentration of 10 mM, was applied to a 1-ml HiTrap chelating HP column (Amersham Biosciences) equilibrated with buffer A containing 10 mM imidazole on fast protein liquid chromatgraphy. For GriI and GriH purification, the column was charged with Co2+ ions and Ni2+ ions, respectively. The column was washed successively with buffer A containing 10 mM imidazole and buffer A containing 50 mM imidazole, and proteins were then eluted with a 50-250 mM linear gradient of imidazole in buffer A. The enzyme solution was concentrated by ultrafiltration and applied to a gel filtration column (HiLoad Superdex 200 16/60 prep grade, Amersham Biosciences) on fast protein liquid chromatgraphy with isocratic elution in buffer B (20 mM HEPES-NaOH, pH 7.2, 0.15 M NaCl, and 20% glycerol) at a flow rate of 1 ml/min. Proteins were quantified by measuring the absorbance of protein solution at 280 nm using the molar absorbance coefficients, 16,500 M-1 cm-1 for GriI and 23,400 M-1 cm-1 for GriH, calculated from their amino acid sequences.

In Vitro Assay of GriI and GriH—The standard reaction mixture (100 µl) consisted of buffer B containing 0.1 mM MnCl2, 1 mM ASA, 1 mM dihydroxyacetone phosphate (DHAP, Fig. 1A), 0.1 mg/ml (3 µM for monomer) GriI, and 0.4 mg/ml (13 µM) GriH. After incubation at 30 °C for 30 min, reaction products were analyzed by HPLC and LC-ESIMS. 3,4-AHBA produced was quantified by a colorimetric method using 4-dimethylaminobenzaldehyde (20), as follows. The reaction was stopped by the addition of 100 µl of 20% trichloroacetic acid (w/v) and then centrifuged. After 4-dimethylaminobenzaldehyde (5%, 400 µl) in acetonitrile/water (9:1 (v/v)) had been added to the supernatant, the absorbance at 450 nm was measured by a spectrometer (Spectra Max plus; Molecular Devices). The amount of 3,4-AHBA was estimated on the basis of the results of the control reactions with authentic 3,4-AHBA.

The GriI reaction was examined using the standard reaction mixture in the absence of GriH and MnCl2. The GriI reaction product, from which GriI was removed by ultrafiltration, was used as a substrate for the GriH reaction. The concentration of the substrate for GriH in the GriI-removed reaction mixture was estimated on the basis of the amount of 3,4-AHBA produced by prolonged incubation of the mixture containing GriH and MnCl2. The kinetics of the GriI reaction was determined by the rate of increase in the 3,4-AHBA concentration in the presence of an excess of GriH; the reaction mixture contained 0.1 mM MnCl2, 20-200 µM ASA, 50-200 µM DHAP, 0.16 µM (for monomer) GriI, and 13 µM GriH in buffer B. Kinetic parameters were determined by non-linear least squares fitting on the equation for the double-displacement mechanism, i.e. 1/v = 1/Vmax (1 + Km,S1/[S1] + Km,S2/[S2]) (21). The kinetics of the GriH reaction was determined by the rate of increase in the 3,4-AHBA concentration in the reaction mixtures containing various volumes of the GriI-removed reaction mixture, 0.1 mM MnCl2, and 1.3 µM GriH in buffer B. Kinetic parameters were determined by linear least squares fitting on the Michaelis-Menten equation (21).


    RESULTS AND DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS AND DISCUSSION
 REFERENCES
 
Identification of Genes Responsible for 3,4-AHBA Biosynthesis—During subcloning of the grixazone biosynthesis genes (Fig. 2A), we found that pAYP26 carrying griI and griH under the control of the melC promoter conferred the production of a grixazone-like yellow pigment on a grixazone-nonproducing mutant strain, S. griseus M31. Both griI and griH were required for pigmentation, because neither pAYP27 carrying griI alone nor pAYP28 carrying griH alone caused pigmentation (Fig. 2B). S. griseus M31 [pAYP26] produced three compounds, 2, 4, and 5 (Fig. 2C, panel a), of which the structures were determined as 3,4-AHBA (2), 3,4-AcAHBA (4), and APOC (5) (Fig. 1A). Addition of 3,4-AHBA to the culture of S. griseus M31 resulted in the conversion of 3,4-AHBA to 3,4-AcAHBA, suggesting that an acetyltransferase(s) of the host catalyzed the N-acetylation of 3,4-AHBA. APOC, a yellow pigment with visible absorption at 433 nm at pH 2.0, was perhaps produced non-enzymatically from 3,4-AHBA, because 3,4-AHBA was converted to APOC during aerobic incubation at 26.5 °C in aseptic SMM. Therefore, pAYP26 carrying griI and griH directed the synthesis of 3,4-AHBA in S. griseus M31.


Figure 2
View larger version (26K):
[in this window]
[in a new window]

 
FIGURE 2.
Biosynthesis of 3,4-AHBA in S. griseus. A, organization of the grixazone biosynthesis gene cluster and plasmids used in this study. B, S. griseus M31 [pAYP26, pAYP27, pAYP28, or the vector pIJ702] was grown at 28 °C for 5 days on SMM agar medium. The yellow pigment produced by M31 [pAYP26] was determined to be APOC that was formed non-enzymatically via oxidative coupling of two 3,4-AHBA molecules. C, reversed-phased HPLC analysis of 3,4-AHBA produced in vivo (panel a) and in vitro (panel b). S. griseus M31 [pAYP26] was cultured at 26.5 °C for 5 days in liquid SMM, and 10µlofthe culture broth was analyzed by HPLC (panel a). The standard GriI-GriH reaction (panel b) and the prolonged GriI reaction (panel b, inset) were analyzed by HPLC.

 
Simultaneous expression of griI and griH caused not only S. griseus M31 but also E. coli to produce 3,4-AHBA (data not shown). E. coli [pET-griIH] that contained a co-translational griI-griH sequence under the control of the T7 promoter produced 3,4-AHBA and 3,4-AcAHBA. An important implication from these findings was that no Streptomyces-specific genes other than griI and griH were necessary for the biosynthesis of 3,4-AHBA. In addition, the precursors that are converted to 3,4-AHBA by the actions of GriI and GriH were supposed to be present as primary metabolites commonly in bacterial cells. griI encodes a 274-amino acid protein showing sequence similarity (about 30-58% identity) to class I aldolases (supplemental Fig. 1s). griH encodes a 396-amino acid protein showing sequence similarity (23-62% identity) to hypothetical proteins belonging to the UPF0245 family (supplemental Fig. 2s).

Estimation of Primary Metabolites Serving as the Substrates for 3,4-AHBA Biosynthesis by Incorporation Experiments Gould and co-workers (11, 22) and Floss and co-workers (23, 24) proposed that 3,4-AHBA was formed from a C4 unit (corresponding to C-7, C-1, C-6, and C-5 of 3,4-AHBA) derived from the tricarboxylic acid cycle and a C3 unit (C-2, C-3, and C-4 of 3,4-AHBA) derived from the glycolytic pathway. Gould and co-workers (22) also proposed the condensation between oxalacetate and either PEP or pyruvate for 3,4-AHBA biosynthesis. To determine the primary metabolite(s) serving as the substrates for the GriI-GriH system, we examined incorporation of 13C-labeled precursors into 3,4-AcAHBA by 13C NMR (Table 1). When [4-13C]aspartate and [2-13C]aspartate were fed, C-5 and C-1 of 3,4-AcAHBA, respectively, were mainly enriched. We therefore assumed that ASA, in addition to oxalacetate, was the most probable candidate for the C4 unit of 3,4-AHBA in agreement with the proposal of Gould and coworkers (22), because these compounds were direct derivatives from aspartate and could be served as a substrate for aldol condensation.

When sodium [3-13C]pyruvate was fed in the absence of glucose or glycerol, C-2 of 3,4-AcAHBA, in addition to C-9 in its acetyl moiety, was mainly enriched. The acetyl moiety was derived probably from acetyl-CoA. This finding is also consistent with the observation by Gould et al. (11). When sodium [3-13C]pyruvate was fed in the presence of glucose or glycerol, however, C-1 and C-6 of 3,4-AcAHBA were enriched, indicating that pyruvate was incorporated into 3,4-AcAHBA after being converted to a precursor of the C4 unit through the tricarboxylic acid pathway. On the other hand, when [1-13C]glucose or [6-13C]glucose was fed, C-2 of 3,4-AcAHBA was highly enriched even in the presence of pyruvate. Similarly, a very high level of enrichment at C-3 of 3,4-AcAHBA was observed when [2-13C]glycerol was fed even in the presence of pyruvate. These results suggested that the C3 unit moiety of 3,4-AHBA was derived from a metabolite upstream from pyruvate in the glycolytic pathway but not pyruvate itself.

In the glycolytic pathway, glucose is converted to fructose 1,6-bisphosphate and cleaved into two C3 units, DHAP and glyceraldehyde 3-phosphate. The carbon at the phosphorylated position of DHAP and that of glyceraldehyde 3-phosphate are derived originally from the C-1 and C-6 carbons of glucose, respectively, although DHAP is reversibly converted into glyceraldehyde 3-phosphate. In our incorporation experiments with [1-13C]glucose and [6-13C]glucose, the level (11.4%) of enrichment at C-2 of 3,4-AcAHBA from [1-13C]glucose was higher than that (7.1%) from [6-13C]glucose. Furthermore, the ratio (the calculated ratio, 11.4/5.5 = 1.96) of enrichment at C-2 to C-9 of the labeled 3,4-AcAHBA derived from [1-13C]glucose was much higher than that (7.0/6.9 = 1.01) from [6-13C]glucose. These results showed that the carbon of C-1 of glucose had been incorporated into C-2 of 3,4-AcAHBA before it was incorporated into acetyl-CoA more efficiently than that of C-6 of glucose. Therefore, in disagreement with the proposal of Gould and co-workers (22), we assumed that DHAP, but not PEP or pyruvate, was the most probable candidate for the C3 unit of 3,4-AHBA. This idea was supported by the finding that C-2 of glycerol, which enters into the glycolytic pathway via DHAP, was incorporated into C-3 of 3,4-AcAHBA very efficiently.


Figure 3
View larger version (25K):
[in this window]
[in a new window]

 
FIGURE 3.
Characteristics of GriI and GriH. A, purified GriI and GriH proteins were separated by SDS-PAGE and stained with Coomassie Brilliant Blue. Myosin (200 kDa), beta-galactosidase (116 kDa), phosphorylase b (97 kDa), bovine serum albumin (67 kDa), ovalbumin (45 kDa), carbonic anhydrase (31 kDa), soybean trypsin inhibitor (22 kDa), lysozyme (14 kDa), and bovine aprotinin (7 kDa) were used for the molecular mass standards. A minor band in the GriI preparation probably represents a degradation product of GriI. B, the plots of the initial velocities of the production of 3,4-AHBA versus concentrations of Mn2+. The initial reaction velocities were determined by using the standard reaction mixture containing various concentrations of MnCl2. GriH concentrations were 13 (•), 1.3 ({blacktriangleup}), and 0.13 ({blacksquare}) µM, and the 50% effective concentrations (EC50, µM) of Mn2+ were estimated as 0.70, 1.41, and 20.3, respectively, by nonlinear least squares fitting on a sigmoidal function: log (V) = log (Vmax) - log (EC50/[Mn2+] + 1). C, the pH profile (panel a) and temperature profile (panel b) of the reaction producing 3,4-AHBA by GriI and GriH, pH stability (panel c), and temperature stability (panel d) of GriI (•) and GriH ({blacksquare}). Standard reaction mixtures were incubated at 30 °C for 30 min at various pH values (panel a) and at various temperatures at pH 7.2 (panel b), and the amounts of 3,4-AHBA formed were measured. The buffer used in panels a and b were buffer C (50 mM sodium phosphate, 50 mM sodium citrate, 0.15 M NaCl, and 20% glycerol, pH 4-11) and buffer B, respectively. pH stability (panel c) was determined by standard assays for the 3,4-AHBA formation, in which GriI or GriH had been kept at 30 °C for 1 h in buffer C adjusted at various pHs. Temperature stability (panel d) were determined by standard assays for the 3,4-AHBA formation, in which GriI or GriH had been kept for 1 h in buffer B at various temperatures. D, Lineweaver-Burke double-reciprocal plot of the GriI reaction (panel a) and GriH reaction (panel b). Concentrations of DHAP were 200 (•), 100 ({blacktriangleup}), and 50 ({blacksquare}) µM in panel a.

 
3,4-AHBA Production in Vitro by GriI and GriH—Histidine-tagged GriI, having the structure of MGSSH6SSGLVPRGSH-GriI, was prepared from S. lividans [pIJ4123-griI]. Similarly, histidine-tagged GriH, having the structure of MGSSH6SSGLVPRGSHGriH, was prepared from S. lividans [pIJ4123-griH]. The molecular masses of GriI and GriH were estimated by gel filtration analysis as 340 and 54 kDa, respectively. Because purified GriI and GriH were apparently 33 and 46 kDa on SDS-PAGE, respectively (Fig. 3A), GriI was probably a decamer-type aldolase (25) and GriH was monomeric.

Using the GriI and GriH proteins, we examined various conditions for the synthesis of 3,4-AHBA. When ASA and DHAP were incubated with GriI and GriH in the presence of 0.1 mM MnCl2 at 30 °C, 3,4-AHBA was produced at a constant rate of about 22 µM/min (2.2 nmol/min) for 30 min (Fig. 2C, panel b). As shown in Fig. 3C, this reaction proceeded over a pH range of 6.0-9.5 with a maximum rate at pH 8.0 at 40 °C. GriI was stable between pH 6.5-10.0 (at 30 °C for 1 h) and below 40 °C (at pH 7.2 for 1 h). GriH was stable between pH 6.5-10.5 (at 30 °C for 1 h) and below 30 °C (at pH 7.2 for 1 h). We examined all combinations of possible C4 units (ASA, oxalacetate, L-aspartate, and L-homoserine) and C3 units (DHAP, PEP, pyruvate, and dihydroxyacetone) as substrates and confirmed that 3,4-AHBA was synthesized only from the combination of ASA and DHAP. Addition of Mn2+ or some bivalent metal ions (0.1 mM) to the reaction mixture was essential for the synthesis of 3,4-AHBA (relative activity: MnCl2, 100%; CoCl2, 85%; FeSO4, 81%; MgSO4, 41%; NiSO4, 6%; ZnSO4, 4%; CaCl2 and CuSO4, <1%).


Figure 4
View larger version (23K):
[in this window]
[in a new window]

 
FIGURE 4.
Proposed pathways from compound 1 to 5,2-APC (A) and 3,4-AHBA (B). A, a proposed mechanism for the non-enzymatic reaction leading to 5,2-APC from the product of the GriI reaction, 1. B, a proposed mechanism for the GriH reaction yielding 3,4-AHBA from the product of the GriI reaction, 1.Mn2+ is essentially required for the GriI-GriH reaction, although it is not illustrated.

 
No Cofactor Requirement for the GriH Reaction—Mn2+ was required for the GriH reaction but not for the GriI reaction, because addition of GriH and MnCl2 to the GriI-removed mixture containing no Mn2+ and incubation of the mixture at 30 °C for 30 min yielded 3,4-AHBA. This experiment also showed that a compound produced as a result of aldol condensation of ASA and DHAP by GriI served as the substrate of GriH, resulting in 3,4-AHBA. The plots of the initial velocities of the production of 3,4-AHBA versus concentrations of Mn2+ showed sigmoidal curves (Fig. 3B), indicating that more Mn2+ was required for the reaction as the amount of GriH was decreased. This finding excluded the possibility that Mn2+ bound tightly to GriH functioned as a normal cofactor. Mn2+ may stabilize the substrate for GriH, i.e. the compound produced as a result of aldol condensation between ASA and DHAP by GriI, by chelating the compound, which was extremely unstable (see below).

Because MJ1249, a GriH homologue of M. jannaschii, requires NAD (4), we examined effects of cofactors on the formation of 3,4-AHBA by GriH. Addition of 0.1 mM each of NAD, NADH, NADP, NADPH, FAD, or FMN to the reaction mixture had negligible effects on the 3,4-AHBA formation (relative activity, 98-107%), although the reaction was partially inhibited by 0.1 mM pyridoxal phosphate (relative activity, 9.4%). Furthermore, HPLC and absorption spectrum analyses of the purified GriH protein showed the absence of any cofactors (data not shown).

Kinetics Analyses of GriI and GriH Reactions—We determined the kinetics of the GriI reaction by measuring the rate of increase in the 3,4-AHBA concentration in the presence of an excess of GriH. Because the reciprocal plots of the GriI reaction showed apparently parallel lines (Fig. 3D, panel a), the kinetic parameters were determined by fitting on the equation for the double-displacement mechanism (kcat, 0.20 ± 0.01 s-1 for monomer; Km for ASA, 5.6 ± 1.5 µM; Km for DHAP, 140 ± 9 µM). The kinetics of the GriH reaction was determined by the rate of increase in the 3,4-AHBA concentration using the GriI-removed reaction mixture (see "Experimental Procedures") as the substrate. The amount of the substrate for GriH (probably compound 1; see below) in the mixture was estimated on the basis of the amount of 3,4-AHBA produced by prolonged incubation of the mixture containing GriH and MnCl2. The reciprocal plots of the GriH reaction followed the Michaelis-Menten kinetics (Fig. 3D, panel b). The kcat and Km values were calculated as 0.025 ± 0.002 s-1 and 12 ± 2 µM, respectively. This Km value for the GriH reaction might be underestimated because the concentration of the GriH substrate determined was perhaps lower than the actual concentration due to the instability of the substrate compound.

Proposed Reaction Pathway of 3,4-AHBA Formation—Although the product of the GriI reaction was extremely unstable, we detected a relatively stable product with absorption at 292 nm at pH 2.0 after prolonged GriI reaction (Fig. 2C, panel b, inset). Because the compound did not serve as a substrate for GriH, it must be a shunt product. The compound was also detected in the culture broth of S. lividans [pIJ4123-griI] and S. griseus [pAYP27] (data not shown). This shunt product was identified as 5,2-APC. We assumed that the actual product of the GriI reaction was 2-amino-4,5-dihydroxy-6-one-heptanoic acid-7-phosphate (1, Fig. 1A), since 5,2-APC was presumably derived from 1 through a rationalized pathway (Fig. 4A). The pathway we propose is as follows. 1 is converted to a Schiff base 1b via formation of 1a by an intramolecular reaction. In 1b, the double bond migrates to produce 3a, which results in dephosphorylation to yield a product 3b. 3b is in equilibrium with 3c and 3d. Ring opening of 3d and subsequent ring closure afford 3f with a pyrrolidine ring, which produces 3g by dehydration. 5,2-APC is formed from 3g by migration of the double bonds. GriI thus catalyzed an aldolase reaction between the aldehyde carbon of ASA and the hydroxylated carbon of DHAP (Fig. 1A).

On the other hand, we detected no intermediates during the GriH reaction, suggesting that several steps in the GriH reaction proceeded consecutively in a substrate-binding pocket of GriH. Considering no requirement of GriH for cofactors involved in oxidative and reductive reactions, we propose a chemically rationalized pathway from the intermediate 1 to 3,4-AHBA (Fig. 4B). In the pathway, 1 is converted to a Schiff base 1b via formation of 1a by an intramolecular reaction. In 1b, the double bond migrates to produce a tautomeric Schiff base 1c, which is in equilibrium with the hydrated form 1d. A ketone 1e formed by dehydration of 1d facilitates dephosphorylation to give an enone 1f. The formation of an enone along with dephosphorylation is known for some enzyme reactions (26, 27). Ring opening of 1f and subsequent aldol condensation affords a carbocyclic compound 1h. A series of reactions from 1e to 1h seems to be reasonable, because similar reactions have been proposed for the DHQ synthase (27) (6 to DHQ in Fig. 1B). 3,4-AHBA is readily formed from the imino-ketone 1h by dehydration.

Comparison of GriI-GriH System with an Alternative DHQ Synthesis Pathway of Archaea—Recently, MJ0400 (a GriI homologue) and MJ1249 (a GriH homologue) of M. jannaschii were reported to be involved in an alternative pathway for DHQ biosynthesis (4). In this pathway, MJ0400 forms 2-amino-3,7-dideoxy-D-threo-hept-6-ulosonic acid (7, Fig. 1B) via a transaldol reaction between the dihydroxyacetone fragment of 6-deoxy-5-ketofructose-1-phosphate and ASA. DHQ is then formed by MJ1249 via NAD-dependent oxidative deamination of 7, producing 8, and subsequent cyclization. Because most Archaea lack the first two key enzymes involved in the synthesis of DHQ (3), MJ0400 and MJ1249 are thought to supply DHQ to the shikimate pathway (4). Interestingly, the reaction catalyzed by GriH is totally different from that catalyzed by MJ1249, despite sequence similarity between GriH and MJ1249. Much less conserved amino acid sequences in the N-terminal portions of GriH and MJ1249 may explain the difference of the reactions catalyzed by these enzymes. On the other hand, the reactions catalyzed by GriI and MJ0400 are analogous. Thus, the biosynthetic pathway of 3,4-AHBA may have evolved from the alternative DHQ synthesis pathway.

The genome data bases predict that griI and griH homologues are present in several bacteria (supplemental Figs. 1s and 2s). These griI and griH homologues are probably involved in the biosynthesis of 3,4-AHBA that serves as a building block of the respective secondary metabolites. Furthermore, griH homologues are found in the genomes of higher plants, such as Arabidopsis thaliana and Oryza sativa, giving the possibility that the benzene ring biosynthetic pathway involving GriH homologues is distributed widely in nature.


    FOOTNOTES
 
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EBI Data Bank with accession number(s) AB259663 [GenBank] .

* This work was supported by Grant 03A07002 from the Industrial Technology Research Grant Program in 2003 of the New Energy and Industrial Technology Development Organization of Japan, by a grant-in-aid for scientific research on priority areas "Applied Genomics" from Monkasho, and by the BioDesign Program of the Ministry of Agriculture, Forestry, and Fisheries of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Back

Formula The on-line version of this article (available at http://www.jbc.org) contains supplemental Methods and Fig. 1s and 2s. Back

{diamondsuit} This article was selected as a Paper of the Week. Back

1 To whom correspondence should be addressed. Tel.: 81-3-5841-5123; Fax: 81-3-5841-8021; E-mail: asuhori{at}mail.ecc.u-tokyo.ac.jp.

2 The abbreviations used are: PEP, phosphoenolpyruvate; 3,4-AcAHBA, 3-acetylamino-4-hydroxybenzoic acid; 5,2-APC, 5-acetyl-1H-pyrrole-2-carboxylic acid; 3,4-AHBA, 3-amino-4-hydroxybenzoic acid; APOC, 2-aminophenoxazin-3-one-8-carboxylic acid; DHQ, 3-dehydroquinate; HPLC, high-performance liquid chromatography; HRESI/TOF-MS, high resolution electrospray ionization-time-of-flight mass spectrum; LC-ESIMS, liquid chromatography-electrospray ionization mass spectrometry; SMM, standard minimal medium. Back

3 The brackets denote the plasmid-carrier state. Back



    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS AND DISCUSSION
 REFERENCES
 

  1. Hillis, L. R., and Gould, S. J. (1985) J. Am. Chem. Soc. 107, 4593-4594[CrossRef]
  2. Knaggs, A. R. (2003) Nat. Prod. Rep. 20, 119-136[CrossRef][Medline] [Order article via Infotrieve]
  3. Woodard, R. W. (2004) Bioorg. Chem. 32, 309-315[CrossRef][Medline] [Order article via Infotrieve]
  4. White, R. H. (2004) Biochemistry 43, 7618-7627[CrossRef][Medline] [Order article via Infotrieve]
  5. Arakawa, K., Müller, R., Mahmud, T., Yu, T.-W., and Floss, H. G. (2002) J. Am. Chem. Soc. 124, 10644-10645[CrossRef][Medline] [Order article via Infotrieve]
  6. Rascher, A., Hu, Z., Buchanan, G. O., Reid, R., and Hutchinson, C. R. (2005) Appl. Environ. Microbiol. 71, 4862-4871[Abstract/Free Full Text]
  7. Funa, N., Ozawa, H., Hirata, A., and Horinouchi, S. (2006) Proc. Natl. Acad. Sci. U. S. A. 103, 6356-6361[Abstract/Free Full Text]
  8. Austin, M. B., and Noel, J. P. (2003) Nat. Prod. Rep. 20, 79-110[CrossRef][Medline] [Order article via Infotrieve]
  9. Ohnishi, Y., Furusho, Y., Higashi, T., Chun, H.-K., Furihata, K., Sakuda, S., and Horinouchi, S. (2004) J. Antibiot. 57, 218-223[Medline] [Order article via Infotrieve]
  10. Suzuki, H., Furusho, Y., Higashi, T., Ohnishi, Y., and Horinouchi, S. (2006) J. Biol. Chem. 281, 824-833[Abstract/Free Full Text]
  11. Gould, S. J., Melville, C. R., and Cone, M. C. (1996) J. Am. Chem. Soc. 118, 9228-9232[CrossRef]
  12. Hu, Y., and Floss, H. G. (2004) J. Am. Chem. Soc. 126, 3837-3844[CrossRef][Medline] [Order article via Infotrieve]
  13. Hopwood, D. A., Bibb, M. J., Chater, K. F., Kieser, T., Bruton, C. J., Kieser, H. M., Lydiate, D. J., Smith, C. P., Ward, J. M., and Schrempf, H. (1985) in Genetic Manipulation in Streptomyces: A Laboratory Manual, The John Innes Foundation, Norwich, UK
  14. Katz, E., Thompson, C. J., and Hopwood, D. A. (1983) J. Gen. Microbiol. 129, 2703-2714[Medline] [Order article via Infotrieve]
  15. Takano, E., White, J., Thompson, C. J., and Bibb, M. J. (1995) Gene (Amst.) 166, 133-137[CrossRef][Medline] [Order article via Infotrieve]
  16. Maniatis, T., Fritsch, E. F., and Sambrook, J. (1982) Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
  17. Black, S., and Wright, N. G. (1955) J. Biol. Chem. 213, 39-50[Free Full Text]
  18. Wang, X., Stumpf, D., and Larkins, B. A. (2001) Plant Physiol. 125, 1778-1787[Abstract/Free Full Text]
  19. Martyn, D. C., Vernall, A. J., Clark, B. M., and Abell, A. D. (2003) Org. Biomol. Chem. 1, 2103-2110[CrossRef][Medline] [Order article via Infotrieve]
  20. Westwood, I. M., Holton, S. J., Rodrigues-Lima., F., Dupret, J.-M., Bhakta, S., Noble, M. E. M., and Sim, E. (2005) Biochem. J. 385, 605-612[CrossRef][Medline] [Order article via Infotrieve]
  21. Copeland, R. A. (2000) Enzymes. A Practical Introduction to Structure, Mechanism and Data Analysis, 2nd Ed., pp. 109-123 and 355-357, Wiley-VCH, New York
  22. Li, Y., Gould, S. J., and Proteau, P. J. (2000) Tetrahedron Lett. 41, 5181-5185[CrossRef]
  23. Hu, Y., Melville, C. R., Gould, S. J., and Floss, H. G. (1997) J. Am. Chem. Soc. 119, 4301-4302[CrossRef]
  24. Thiericke, R., Zeeck, A., Nakagawa, A., Omura, S., Herrold, R. E., Wu, S. T. S., Beale, J. M., and Floss, H. G. (1990) J. Am. Chem. Soc. 112, 3979-3987[CrossRef]
  25. Lorentzen, E., Pohl, E., Zwart, P., Stark, A., Russell, R. B., Knura, T., Hensel, R., and Siebers, B. (2003) J. Biol. Chem. 278, 47253-47260[Abstract/Free Full Text]
  26. Yeh, J. I., Du, S., Pohl, E., and Cane, D. E. (2002) Biochemistry 41, 11649-11657[CrossRef][Medline] [Order article via Infotrieve]
  27. Carpenter, E. P., Hawkins, A. R., Frost, J. W., and Brown, K. A. (1998) Nature 394, 299-302[CrossRef][Medline] [Order article via Infotrieve]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Bacteriol.Home page
T. Higashi, Y. Iwasaki, Y. Ohnishi, and S. Horinouchi
A-Factor and Phosphate Depletion Signals Are Transmitted to the Grixazone Biosynthesis Genes via the Pathway-Specific Transcriptional Activator GriR
J. Bacteriol., May 1, 2007; 189(9): 3515 - 3524.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
H. Suzuki, Y. Ohnishi, and S. Horinouchi
Arylamine N-Acetyltransferase Responsible for Acetylation of 2-Aminophenols in Streptomyces griseus
J. Bacteriol., March 1, 2007; 189(5): 2155 - 2159.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
281/48/36944    most recent
M608103200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Suzuki, H.
Right arrow Articles by Horinouchi, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Suzuki, H.
Right arrow Articles by Horinouchi, S.
Related Collections
Right arrow Papers Of The Week
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.